Potentiating Supplements to Use during the SuCCeED IVC Protocol

Below are listed some of the supplements that have significantly demonstrated efficacy in potentiating the ability of very high-dose intravenous vitamin C to kill cancer (40g/hr. +/-20g, for 1-3 hours).  It is expected that they will also have the same potentiating effect with the SuCCeED IVC Protocol.

• • Alpha Lipoic Acid¹
  • Vitamin E ²
  • Vitamin K3 if possible (Apatonetm)^1,3, otherwise do take Vitamin K1 or K2 ⁴
  • Lecithin⁵
  • Artemisinin if possible⁶
  • D­fraction (Maitake mushroom) supplement if possible⁷
  • DCA (dichloroacetate)⁸
  • Quercetin³
  • Curcumin³
  • Do with other oxidative therapies. Hypoxia at the cancer site is likely the #1 reason when treatment efficacy falls short of in vitro success. Here’s how to mitigate that:
    • O2 Mask
    • Ozone generator in the room
    • Hyperbaric Oxygen
    • DCA (dichloroacetate) administration
    • Exercise Bike, increases blood flow to tumor and oxygenation
  • Do reasonable Conventional Chemotherapy

Note some of these are available in a combined supplement called IVC Max (by Aidan Products, associated with the Riordan Clinic).  This is easily found with a websearch.  It contains many of the supplements mentioned herein specifically for the purpose of potentiating IVC.  The ingredients as of this published date as shown in this nutrition fact label shown here.

It is mentioned here as definitely being beneficial because of the Vitamin K1, ALA, and Quercetin, which is convenient to have in one supplement.  The additional ingredients should have a possible to likely effect in improving efficacy.

References

1. JJ Casciari, NH Riordan, TL Schmidt, XL Meng, JA Jackson, and HD Riordan; Cytotoxicity of
   ascorbate, lipoic acid, and other antioxidants in hollow fibre in vitro tumours; British Journal of
   Cancer (2001) 84(11), 1544–1550 doi: 10.1054/ bjoc.2001.1814,;
   http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363673
2. Tomasetti M, Strafella E, Staffolani S, Santarelli L, Neuzil J, Guerrieri R.; alpha­Tocopheryl
   succinate promotes selective cell death induced by vitamin K3 in combination with ascorbate.; Br
   J Cancer. 2010 Apr 13;102(8):1224­34. doi: 10.1038/sj.bjc.6605617. Epub 2010 Mar 23.;
   https://www.ncbi.nlm.nih.gov/pubmed/20332775
3. Lamson DW, Gu YH, Plaza SM, Brignall MS, Brinton CA, Sadlon AE.; The vitamin C:vitamin K3
   system ­ enhancers and inhibitors of the anticancer effect.; Altern Med Rev. 2010
   Dec;15(4):345­51.; https://www.ncbi.nlm.nih.gov/pubmed/21194250
4. Verrax J, Taper H, Buc Calderon P.; Targeting cancer cells by an oxidant­based therapy.; Curr Mol
   Pharmacol. 2008 Jan;1(1):80­92.; https://www.ncbi.nlm.nih.gov/pubmed/20021426
5. Pancorbo D, Vazquez C, Fletcher MA.; Vitamin C­lipid metabolites: uptake and retention and
   effect on plasma C­reactive protein and oxidized LDL levels in healthy volunteers.; Med Sci Monit.
   2008 Nov;14(11):CR547­51.; http://www.ncbi.nlm.nih.gov/pubmed/18971870
6. Efferth T.; Molecular pharmacology and pharmacogenomics of artemisinin and its derivatives in
   cancer cells.; Curr Drug Targets. 2006 Apr;7(4):407­21.;
   http://www.ncbi.nlm.nih.gov/pubmed/16611029
7. Alexander B1, Fishman AI, Eshghi M, Choudhury M, Konno S.; Induction of cell death in renal cell
   carcinoma with combination of D­fraction and vitamin C.; Integr Cancer Ther. 2013
   Sep;12(5):442­8. doi: 10.1177/1534735412473643. Epub 2013 Jan 22.;
   https://www.ncbi.nlm.nih.gov/pubmed/23341484
8. Akbar Khan, MD; Denis Marier, ND; Eric Marsden, ND; Douglas Andrews, ND; Isaac Eliaz, MD; A
   Novel Form of Dichloroacetate Therapy for Patients With Advanced Cancer: A Report of 3 Cases;
   ALTERNATIVE THERAPIES, VOL. 20, SUPPL. 2 27
   http://alternative­therapies.com/at/web_pdfs/s202khan.pdf